Muhammad Khan, MD
Hematology & Oncology · Plantation, FLNPI 1427481472
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 9.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,469, 5.3 times the $278 reported in 2021. That places this record below the midpoint for hematology & oncology clinicians in FL, where the typical reported total is $3,884.
Across 79 payments — averaging $27.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$213
- Genentech USA, Inc.$137
- Pfizer$131
- AbbVie$126
- Rigel Pharmaceuticals, Inc.$125
- Merck$118
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,171100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 8 | $213 |
| Genentech USA, Inc. | 5 | $137 |
| Pfizer | 5 | $131 |
| AbbVie | 5 | $126 |
| Rigel Pharmaceuticals, Inc. | 1 | $125 |
| Merck | 5 | $118 |
| Sobi, Inc | 2 | $92 |
| AVEO Pharmaceuticals, Inc. | 1 | $92 |
| Novartis | 3 | $80 |
| Tempus AI, Inc | 3 | $69 |
| Legend Biotech USA Inc. | 3 | $60 |
| Adaptive Biotechnologies Corporation | 2 | $60 |
| Array Biopharma Inc | 2 | $58 |
| GSK | 2 | $58 |
| Taiho Oncology, Inc. | 2 | $57 |
| Novocure Inc. | 2 | $52 |
| Johnson & Johnson | 2 | $52 |
| Incyte Corporation | 2 | $51 |
| Evoke Pharma, Inc. | 3 | $45 |
| Agios Pharmaceuticals, Inc. | 1 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Iovance Biotherapeutics, Inc. | 1 | $31 |
| Sanofi | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $28 |
| Caris MPI, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Abbott | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| ADC Therapeutics America, Inc. | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Gilead | 1 | $21 |
| Tolmar, Inc. | 1 | $21 |
| Pharmaand GmbH | 1 | $21 |
| Exelixis Inc. | 1 | $21 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $20 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tavalisse$125
How this compares
$2,171 in reported general payments places this provider in the 40th percentile of 694 hematology & oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 18 | $249 |
| Prednisone | 17 | $60 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Plantation
- Harshad AminPlantation$159K
- Martin DietrichRockledge$6.2M
- Mark SocinskiOrlando$2.4M
- Tarek MekhailOrlando$2.2M
- Edgardo SantosFort Lauderdale$2M
- Daniel LandauOrlando$1.8M
- Wassim McHaylehAltamonte Springs$1.5M
- Edith PerezJacksonville$1.1M
- Steven FeinMiami$1M
- Vamsidhar VelchetiJacksonville$966K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.